Add BrightSurf on Google Email

The RESILIENCE trial: Preventing heart injury caused by anticancer drugs

The RESILIENCE clinical trial explores the effectiveness of remote ischemic conditioning to prevent cardiotoxicity in lymphoma patients undergoing anthracycline-based chemotherapy. The trial aims to reduce heart failure prevalence and improve quality of life for cancer survivors.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEuropean Journal of Heart Failure·TypeRandomized controlled/clinical trial·DateSep 13, 2024

Scientists discover potential cause of an enigmatic vascular disease primarily impacting women

Researchers identified changes in the UBR4 gene as a key driver of fibromuscular dysplasia, a blood vessel disorder affecting up to five percent of adults. The discovery could lead to therapeutic approaches for the condition, particularly beneficial for women who account for 90% of cases.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Cardiovascular Research·TypeExperimental study·DateSep 13, 2024

Mitral valve repair via catheter offers better outcomes than pharmacological treatment in patients with heart failure

A recent study published in the New England Journal of Medicine demonstrates the benefits of catheter-based mitral valve repair for patients with moderate to severe mitral regurgitation. The procedure showed a significant reduction in recurrent hospitalisations and improved quality of life after 12 months.

SourceGermans Trias i Pujol Research Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 12, 2024

Cardiac rehabilitation knowledge, attitudes, and practice among patients with heart failure and cardiology healthcare providers

A study examines cardiac rehabilitation (CR) knowledge, attitudes, and practice (KAP) among patients with heart failure and cardiology healthcare providers. Key findings highlight the importance of proper knowledge and attitudes in effective self-management, indicating potential room for improvement.

SourceCompuscript Ltd·JournalCardiovascular Innovations and Applications·DateSep 4, 2024

Pregnancy-related heart failure is under-detected; AI-enabled stethoscope helped doctors diagnose twice as many cases

A study at the European Society of Cardiology Congress found that an AI-enabled digital stethoscope helped doctors identify twice as many cases of pregnancy-related heart failure compared to a control group. The tool was 12 times more likely to flag heart pump weakness, leading to better diagnosis and potentially life-saving treatment.

SourceMayo Clinic·JournalNature Medicine·DateSep 3, 2024

Brigham-led clinical trial finds finerenone reduces worsening heart failure and cardiovascular death

A randomized, placebo-controlled trial found finerenone improved outcomes in patients with heart failure and mildly reduced or preserved ejection fraction. The drug also showed benefits regardless of the ejection fraction and even in patients on other approved therapies.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 1, 2024

New ESC Guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity of whole arterial system

The new guidelines evaluate PAAD as part of the same cardiovascular system, acknowledging the interconnectedness between aortic and peripheral vascular diseases. The updated recommendations focus on chronic management, screening, and comprehensive treatment strategies to improve treatment outcomes.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·DateAug 30, 2024

Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD

A new substudy of the SELECT Trial found that semaglutide reduced rates of all-cause death, CV death, and non-CV death, including death from COVID-19, in patients with overweight or obesity and established cardiovascular disease without diabetes. Semaglutide also showed protective effects against COVID-19-related adverse events.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateAug 30, 2024

New Chronic Coronary Syndrome (CCS) Guidelines expand diagnostic tools and ways to prevent major adverse events and enhance quality of life

The new guidelines emphasize the importance of detecting non-obstructive coronary artery disease (NOCA/INOCA) caused by microcirculation dysfunction. A risk factor-weighted clinical likelihood model helps estimate pre-test likelihood, allowing for targeted testing and treatment. The guidelines also recommend invasive coronary functiona...

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·DateAug 30, 2024

Brigham-led study finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemic

A recent study led by Brigham and Women's Hospital found that semaglutide reduced deaths from cardiovascular disease and infections, including COVID-19, in obese and overweight patients. The study involved over 17,000 participants and showed a 19% lower overall death rate compared to placebo.

SourceBrigham and Women's Hospital·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateAug 30, 2024

Study reveals best exercise for diabetes patients

A new study found that interval exercise is better suited for men with low blood sugar levels, while continuous exercise is more effective for women. The research suggests that gender-specific recommendations should be considered when prescribing aerobic exercise to patients with type-1 diabetes.

SourceStaffordshire University·JournalThe American Journal of Cardiology·TypeRandomized controlled/clinical trial·DateAug 21, 2024

Stock market turbulence linked to increased risk of heart attacks, strokes, and suicide: A groundbreaking study analyzes 12 million deaths

A groundbreaking study analyzing 12 million deaths finds that stock market volatility is associated with a heightened risk of major adverse cardiovascular events (MACEs) and suicide. Daily stock returns show significant correlations with mortality risks, particularly among older adults, males, and those with lower education levels.

SourceEngineering·JournalEngineering·DateAug 1, 2024

Kidney dysfunction may predict sudden cardiac death in patients with heart failure

A recent study published in ESC Heart Failure found that kidney dysfunction can be used as a criterion to stratify patients requiring implantable defibrillators. The research identified two key independent predictors for the risk of sudden cardiac death: left ventricular ejection fraction and estimated glomerular filtration rate.

SourceFujita Health University·JournalESC Heart Failure·TypeObservational study·DateJul 29, 2024

New UAB study evaluates cardiovascular health scores in predicting mortality risks

A nationwide study from University of Alabama at Birmingham compares two cardiovascular health metrics, Life’s Simple 7 and Life’s Essential 8, with the well-established Pooled Cohort Equation to determine their predictive values for mortality. The researchers found that PCEs outperformed LE8 and LS7 scores in mortality risk prediction.

SourceUniversity of Alabama at Birmingham·JournalJACC Advances·TypeData/statistical analysis·DateJul 22, 2024

Artificial intelligence speeds up heart scans, saving doctors’ time, and could lead to better treatment for heart conditions

Researchers developed an AI model to analyze heart MRI scans, which can save NHS time and resources. The model provides a complete analysis of the entire heart using a view that shows all four chambers, leading to faster and more accurate diagnosis of heart failure and other cardiac conditions.

SourceUniversity of East Anglia·JournalEuropean Radiology Experimental·TypeRandomized controlled/clinical trial·DateJul 11, 2024

Pulsed field ablation procedures found safe and effective for atrial fibrillation patients

A recent study published in Nature Medicine has shown that pulsed field ablation (PFA) is a safe and effective treatment for patients with atrial fibrillation. The study analyzed over 17,600 patients and found no significant risk of esophageal damage or other complications, increasing confidence in the use of PFA technology.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Medicine·TypeObservational study·DateJul 8, 2024

Pusan National University researchers assess the impact of repeated item development faculty training on item difficulty prediction

A study by Pusan National University researchers found that repeated item development training enhances faculty members' accuracy in predicting and adjusting item difficulty levels, leading to better educational outcomes. The training improved the quality of MCQ assessments in medical education.

SourcePusan National University·JournalBMC Medical Education·TypeExperimental study·DateJul 1, 2024

With $12 million NIH grant renewal, Lewis Katz School of Medicine researchers to explore novel cell mechanism in heart injury and repair

Researchers at the Lewis Katz School of Medicine will investigate how injured heart cells communicate with other cells throughout the body using microvesicles known as exosomes. The study aims to understand how specific molecules, such as microRNAs, facilitate communication pathways between cells in the heart and vasculature.

"A hearty debate" concludes plant-based meat alternatives are healthier for your heart than meat

A Canadian Journal of Cardiology review article finds that plant-based meat alternatives tend to reflect a heart-healthy dietary pattern, improving cholesterol levels and blood pressure. The authors recommend incorporating PBMAs into a healthy diet as an excellent protein source, with options lower in saturated fat and sodium.

SourceElsevier·JournalCanadian Journal of Cardiology·TypeSystematic review·DateJun 26, 2024